Editor's letter


Richard Jory

Endemic wrongdoing in Italy has for many years elicited extreme responses from regulators, as they react yet again to the dismal record of misselling and the now beleaguered (and poor) Italian retail investor. It is no consolation that the brash selling practices of all financial instruments - not just structured products - have damaged the wealth, or worse, the retirement income, of Italy's investor community.

Against that backdrop, it is easy to see why Commissione Nazionale per le Societa e la Borsa (Consob), the Italian financial market regulator, has come up with a Mifid implementation draft document that has irked almost the entire community of structured products bankers in Europe. Banks and trade associations alike are crying foul over the degree of disclosure requirements that Consob is suggesting are quite reasonable in its Level 3 - Regulations for Intermediaries consultation document.

The conclusion to this new Italian derivatives debate/scandal/horror - however you want to coin it - will be reached in September, when the regulator expects to produce a final legal document. All of that may run smoothly, unless the European Commission decides that it must take a hand in the writing of an implementation process that all other countries will have to follow in some way.

While the furore rages in Italy, seek some light-hearted relief from the cut and thrust by reading the newest addition to the magazine - Lookback, a column that includes the highs, lows, oddities and notes of interest that we have uncovered during the past month.

Richard Jory


+44 (0)20 7484 9802.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here